Kendle confirms Latin American deal

By staff reporter

- Last updated on GMT

Related tags: Latin america, Brazil

Kendle, who has been expanding its reach across the globe,
targeting the emerging Asia Pacific and Latin American markets, has
announced the acquisition of Latin American-based contract research
organisation, International Clinical Research.

The deal adds new operations in Argentina, Brazil, Colombia and Chile to Kendle's Phase II-IV clinical development capabilities.

Kendle already has operations in Mexico and Peru, and recently reorganised its global business into five regions made up of North America, Europe, Asia/Pacific, Latin America and Africa.

The acquisition, expected to be completed in the second quarter, is the culmination of an ongoing relationship between the two companies, who have worked together in recent years on drug development programs in Latin America.

Kendle will acquire the company for an undisclosed cash amount although specific terms of the agreement were not disclosed. It is expected to be modestly accretive to earnings in 2006 and will operate under the Kendle name.

"We believe this merger will provide great benefit to the development of clinical research in Latin America,"​ said Raul Bozzo, founder of International Clinical Research.

"Kendle's reach will bring a wider variety of trials to the region, and our specialised staff and country-specific expertise will add value to Kendle's Latin American operations," he said.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more